Candesartan 8MG 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FAXUR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,571
Award facts
- Contract value 100% obligated
- $19,571.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $19,571.15 delivery order to AmerisourceBergen Drug Corp on April 2, 2026, for Candesartan 8mg 90-count tablets, with ultimate completion on April 3, 2026.
The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which supports pharmaceutical supply to military healthcare systems globally. Place of performance is Conshohocken, PA. Pricing is firm fixed price. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FAXUR?
SPE2DR26FAXUR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 2, 2026.
How much is contract SPE2DR26FAXUR worth?
The government has obligated $19,571 on SPE2DR26FAXUR.
Is contract SPE2DR26FAXUR an order under another contract?
Yes. SPE2DR26FAXUR is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAXUR competed?
The extent of competition for SPE2DR26FAXUR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award